GSK Investigational Site
Seoul, 137-701, South Korea
NCT Number: NCT01227369
Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Looking for future studies?
Notify Me18 year and older
Female
Observational
Seoul, 137-701, South Korea
Cross-sectional quality of life survey using self-administered OPSAT-QTM questionnaire in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A linguistically validated Korean version of OPSAT-Q
Time frame: 0day
Time frame: oday
GlaxoSmithKline
Industry
Acronym: BRAVO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05493761
Bone Diseases, Bone Diseases, Metabolic
Thessaloniki, Greece
View Trial DetailsNCT07717788
Bone Diseases, Bone Diseases, Metabolic
Najaf, Iraq
View Trial DetailsNCT06375668
Bone Density, Low, Bone Diseases
Bytom, Poland
View Trial DetailsNCT05395091
Bone Diseases, Bone Diseases, Metabolic
Plovdiv, Bulgaria
View Trial Details